Drug discovery and development for fibromyalgia using practical biomarkers throughout the process from relevant animal models to patients.

Nagakura, Yukinori; Tozaki-Saitoh, Hidetoshi; Takeda, Hiroshi

Nagakura, Yukinori; Tozaki-Saitoh, Hidetoshi; Takeda, Hiroshi.

Affiliation

Nagakura Y; School of Pharmacy at Fukuoka, International University of Health and Welfare, Fukuoka, Japan.
Tozaki-Saitoh H; School of Pharmacy at Fukuoka, International University of Health and Welfare, Fukuoka, Japan.
Takeda H; School of Pharmacy at Fukuoka, International University of Health and Welfare, Fukuoka, Japan.

Expert Opin Drug Discov ; 18(5): 539-549, 2023 05.

Article in En | MEDLINE | ID: mdl-37051616

Subject(s)

Chronic Pain; Fibromyalgia; Animals; Fibromyalgia/drug therapy; Chronic Pain/drug therapy; Drug Discovery; Biomarkers; Models, Animal

Key words

Animal model; fibromyalgia; immune dysregulation; monitoring biomarker; pathophysiology; predictive biomarker

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromyalgia / Chronic Pain Type of study: Prognostic_studies Limits: Animals Language: En Journal: Expert Opin Drug Discov Year: 2023 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google